{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:18:14Z","timestamp":1789417094354,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022J05144"],"award-info":[{"award-number":["2022J05144"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372316"],"award-info":[{"award-number":["82372316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030063"],"award-info":[{"award-number":["82030063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302603"],"award-info":[{"award-number":["82302603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijid.2025.108139","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:01:14Z","timestamp":1760803274000},"page":"108139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The diagnostic value of hepatitis B core-related antigen in occult hepatitis B virus infection and its related hepatocellular carcinoma"],"prefix":"10.1016","volume":"161","author":[{"given":"Fuguo","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caorui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qishui","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108139_bib0001","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0002","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0003","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S2468-1253(22)00201-1","article-title":"Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis","volume":"7","author":"Im","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.840825","article-title":"The serious challenge of occult hepatitis B virus infection-related hepatocellular carcinoma in China","volume":"13","author":"Xia","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijid.2025.108139_bib0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jinf.2009.02.013","article-title":"Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China","volume":"58","author":"Fang","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2025.108139_bib0006","first-page":"1425","article-title":"Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)","volume":"11","author":"You","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0007","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2019.11.003","article-title":"2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty, Berg T, et al. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference\u2021","volume":"72","author":"Cornberg","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0008","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2020.05.042","article-title":"Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance","volume":"73","author":"Mak","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0009","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cgh.2019.06.029","article-title":"Among patients with undetectable hepatitis B surface antigen and hepatocellular carcinoma, a high proportion has integration of HBV DNA into hepatocyte DNA and no cirrhosis","volume":"18","author":"Wong","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/v9060139","article-title":"Detection of HBV covalently closed circular DNA","volume":"9","author":"Li","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2025.108139_bib0011","article-title":"High-sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable","volume":"13","author":"Wang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijid.2025.108139_bib0012","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/ajg.2017.397","article-title":"Isolated anti-HBc: the relevance of hepatitis B core antibody-A review of new issues","volume":"112","author":"Wu","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ijid.2025.108139_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01695-20","article-title":"Characterization of hepatitis B precore\/core-related antigens","volume":"95","author":"Hong","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2025.108139_bib0014","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/liv.13346","article-title":"Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA","volume":"37","author":"Wong","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.ijid.2025.108139_bib0015","doi-asserted-by":"crossref","first-page":"e01303","DOI":"10.1128\/JCM.01303-18","article-title":"Correlation of HBcrAg with intrahepatic hepatitis B virus total DNA and covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients","volume":"57","author":"Wang","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2025.108139_bib0016","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/jvh.13061","article-title":"Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA","volume":"26","author":"Chen","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijid.2025.108139_bib0017","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jhep.2018.11.030","article-title":"Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients","volume":"70","author":"Testoni","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0018","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/apt.14376","article-title":"Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection","volume":"47","author":"Mak","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ijid.2025.108139_bib0019","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/apt.15108","article-title":"Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues","volume":"49","author":"Hosaka","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ijid.2025.108139_bib0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2016.03.013","article-title":"HBcrAg predicts hepatocellular carcinoma development: an analysis using time-dependent receiver operating characteristics","volume":"65","author":"Tada","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0021","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1002\/ccr3.3360","article-title":"Hepatitis B virus core\u2013related antigen is useful for surveillance of hepatocellular carcinoma recurrence in a patient with occult hepatitis B virus infection: case report","volume":"8","author":"Yokoyama","year":"2020","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.ijid.2025.108139_bib0022","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0023","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2018.10.003","article-title":"Over-gap PCR amplification to identify presence of replication-competent HBV DNA from integrated HBV DNA: an updated occult HBV infection definition","volume":"70","author":"Liu","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0024","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5604\/01.3001.0012.0927","article-title":"Frequency and characteristics of occult hepatitis B infection among hepatocellular carcinoma patients in Japan","volume":"17","author":"Muto","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0025","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","article-title":"Statements from the Taormina expert meeting on occult hepatitis B virus infection","volume":"49","author":"Raimondo","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0026","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/ajg.2016.436","article-title":"Association of hepatitis B core-related antigen with hepatitis B virus reactivation in occult viral carriers undergoing high-risk immunosuppressive therapy","volume":"111","author":"Seto","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ijid.2025.108139_bib0027","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3350\/cmh.2021.0012","article-title":"Three heads are better than two: hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma","volume":"27","author":"Wu","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0028","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.cgh.2022.06.018","article-title":"Serum HBcrAg and hepatocellular carcinoma in a Taiwanese population seronegative for HBsAg and anti-HCV","volume":"21","author":"Hsieh","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ijid.2025.108139_bib0029","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/liv.13613","article-title":"More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma","volume":"38","author":"Jun","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.ijid.2025.108139_bib0030","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/infdis\/jiv572","article-title":"Hepatitis B virus (HBV) core-related antigen during Nucleos(t)ide analog therapy is related to intra-hepatic HBV replication and development of hepatocellular carcinoma","volume":"213","author":"Honda","year":"2016","journal-title":"J Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:02:00Z","timestamp":1780664520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225003613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"alternative-id":["S1201971225003613"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108139","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnostic value of hepatitis B core-related antigen in occult hepatitis B virus infection and its related hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108139"}}